GLAIVE MEDICAL OPTICS INC

Medtech · Private

Implantable intraocular lens with electronic optical phased array that shifts visible light phase to redirect focus onto viable retinal regions

Grants
$305K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
6
0 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Development of A Novel Visible-Light Phase Shifter and Intraocular Lens to Improve Vision for Those With Age-Related Macular Degeneration$304,998
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2229Sparta Science——
2230PHOEBUS OPTOELECTRONICS LLC——
2231CLEVELAND MEDICAL DEVICES, INC.——
2232GLAIVE MEDICAL OPTICS INC——
2233MACULA VISION SYSTEMS INC.——
2234Neuro Devices, Inc.——
2235NOCTURNAL PRODUCT DEVELOPMENT, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 6
  • Low Power Electronic Vision System Using Ocular Deviceapplication
  • Electronic Vision System Using Ocular Device And Neural Deviceapplication
  • Ocular Device Having Passthrough Lens And Electronic Projectionapplication
  • Circuitous Path Image Projection Onto Retina From Electronic Intraocular Lens (iol)application
  • Linear Path Image Projection Onto Retina From Electronic Intraocular Lens (iol)application
  • Electronic Surgical Eye Implant Including Smart Hapticsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.